The 8 analysts offering 1 year price forecasts for RCEL have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to RCEL in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RCEL EPS for the last quarter is −0.62 USD despite the estimation of −0.43 USD. In the next quarter EPS is expected to reach −0.34 USD. Track more of Avita Medical, Inc. financials and stay on top of what is up with the company.
In the next quarter Avita Medical, Inc. revenue is expected to reach 23.17 M USD. Check out Avita Medical, Inc. revenue and earnings and make informed decisions.
According to analysts, RCEL price target is 16.74 USD with a max estimate of 26.00 USD and a min estimate of 10.56 USD. Check if this forecast comes true in a year, meanwhile watch Avita Medical, Inc. stock price chart and keep track of the current situation with RCEL news and stock market news.
We've gathered opinions of 8 analysts rating RCEL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.